The conversation around ageing is changing.
For many years, aesthetic medicine focused on replacing what had been lost. More volume. More lift. More correction.
Today, patients are increasingly asking different questions.
“How do I maintain healthy skin for longer?”
“How do I support collagen production?”
“How do I age well without looking different?”
This shift has led to the rise of regenerative aesthetics, a branch of aesthetic medicine focused on supporting the body’s own repair processes rather than simply replacing volume.
Two of the most established regenerative treatments available today are Ellansé (洢莲丝) and Sculptra. Both are collagen biostimulators. Both stimulate your body’s own collagen production. Both can play an important role within a long-term skin longevity strategy. However, when comparing Ellansé vs Sculptra, they work very differently.
At Mediject Clinic, where Dr Sheila Li serves as a UK trainer for Ellansé, we use both treatments. The question is rarely which product is better. The more important question is which treatment best supports your anatomy, your goals, and the way your face is ageing.
Our approach to regenerative aesthetics
At Mediject, we believe aesthetic medicine should work with the body’s biology, not against it.
Rather than simply replacing what has been lost, regenerative treatments aim to support the skin’s natural ability to repair, restore, and maintain itself. This philosophy sits at the heart of how we approach facial ageing. The goal is not to chase youth. It is to support healthy ageing, preserve facial identity, and help patients continue to look like themselves for longer.
Treatments such as Ellansé and Sculptra are tools within that wider strategy.
Why collagen matters more than volume
As we age, the face undergoes far more than simple volume loss.
Collagen production declines, elastin fibres weaken, skin quality changes, and facial support gradually reduces. Research suggests collagen production decreases by approximately 1% per year from our mid-twenties onwards. In women, this decline accelerates significantly during the menopausal transition.
These changes contribute to reduced skin firmness, loss of elasticity, changes in facial support, increased skin laxity, and more visible signs of ageing overall.
Regenerative treatments aim to address these structural changes by encouraging the body to produce new collagen rather than simply replacing volume.
Collagen banking and skin longevity
Increasingly, patients in their thirties and forties are exploring regenerative treatments as part of a collagen banking strategy.
Collagen banking refers to supporting collagen production before significant collagen loss occurs. Much like contributing to a pension before retirement, the goal is to invest in your skin’s future rather than waiting for visible ageing to develop.
The aim is not to prevent ageing. The aim is to help the skin age more gradually, maintaining resilience, structure, and skin quality for longer.
This concept sits at the centre of modern skin longevity medicine.
What is inflammageing?
One of the most important concepts emerging within longevity medicine is inflammageing.
Inflammageing describes the chronic low-grade inflammation that develops as we age. Unlike acute inflammation, which helps the body heal after injury, chronic inflammation can contribute to collagen breakdown, impaired cellular repair, and accelerated skin ageing.
Increasingly, regenerative treatments are being incorporated into broader strategies that support healthier skin function, structural integrity, and long-term resilience. This represents a shift away from correction and towards prevention, preservation, and healthy ageing.
Ellansé vs Sculptra and the science behind the treatments
Ellansé and Polycaprolactone (PCL)
Ellansé uses polycaprolactone (PCL), a biodegradable polymer that has been used safely in medicine for decades, including in absorbable sutures and medical devices.
In aesthetic medicine, PCL microspheres are suspended within a gel carrier. The carrier provides immediate structural support, whilst the microspheres gradually stimulate collagen production over time. One of the reasons PCL has become increasingly important within regenerative aesthetics is its ability to combine immediate support with long-term collagen stimulation.
Many patients appreciate seeing an early improvement whilst still benefiting from ongoing regeneration over the months that follow. Depending on the formulation selected, Ellansé results can last between one and four years.
Sculptra and Poly-L-Lactic Acid (PLLA)
Sculptra uses poly-L-lactic acid (PLLA), another biodegradable polymer with a long history of medical use.
PLLA works differently. Rather than providing immediate support, it stimulates collagen production through a controlled inflammatory response. Results develop gradually over multiple treatment sessions and continue improving over several months.
Both materials are well established within aesthetic medicine. The decision between them is less about which material is superior and more about which treatment journey best suits the individual patient.
How many sessions does each require?
Ellansé
Ellansé is typically delivered in a single treatment session. Patients often notice some immediate improvement from the gel carrier, whilst collagen stimulation develops progressively over the following weeks and months. Depending on the formulation selected, results may last between one and four years.
Sculptra
Sculptra typically requires a course of treatment, usually involving three sessions spaced 4 to 6 weeks apart. Collagen production develops gradually and the full effect may not be visible until several months after the final session.
For some patients this slower approach is appealing. Others prefer the more contained treatment journey that Ellansé provides.
What to expect after treatment
Ellansé provides some immediate structural support through its carrier gel, followed by ongoing collagen stimulation. Sculptra generally produces little visible change immediately after treatment, with improvements emerging gradually over subsequent months.
Neither approach is inherently better. They simply suit different patient preferences and treatment goals.
Ellansé Safety considerations
Both Ellansé and Sculptra have strong safety profiles when used by experienced clinicians. Common side effects include temporary swelling, tenderness, redness, and bruising.
Both treatments can be associated with delayed nodules, although the mechanisms differ and the incidence remains low when appropriate protocols are followed. Neither treatment can be dissolved in the way that hyaluronic acid fillers can. This makes consultation, patient selection, and treatment planning particularly important.
At Mediject, every treatment recommendation begins with a comprehensive assessment because the safest treatment is always the right treatment for the right patient.
Asian facial ageing and regenerative aesthetics
While every individual ages differently, ethnicity influences how ageing presents.
Asian patients often retain facial volume for longer than Caucasian patients but may experience changes in skin quality, facial support, and lower-face definition in different ways. Treatment strategies developed for Caucasian faces are not always appropriate for Asian patients.
At Mediject, treatment planning considers anatomy, ethnicity, facial proportions, and facial identity. The goal is never to create a standardised aesthetic. It is to preserve harmony whilst respecting individual features.
This approach is particularly important when using collagen stimulators, where subtle structural changes accumulate gradually over time.
Why Ellansé is often our first recommendation
At Mediject, we use both Ellansé and Sculptra. However, when considering Ellansé vs Sculptra, Ellansé is often our preferred choice because it aligns closely with our philosophy of regenerative aesthetics.
It combines immediate support with long-term collagen stimulation. It typically requires fewer treatment sessions. It integrates naturally into collagen banking and skin longevity strategies. And it allows us to support structural ageing whilst maintaining natural-looking outcomes.
Dr Sheila’s role as a UK trainer for Ellansé reflects a genuine belief in the science behind polycaprolactone and its place within modern regenerative medicine. That belief informs every treatment delivered at Mediject.
For a comprehensive understanding of what Ellansé involves and how it works, our full guide covers everything you need to know.
Frequently asked questions
Which lasts longer, Ellansé or Sculptra?
Ellansé offers a defined longevity profile ranging from one to four years depending on the formulation used. Sculptra also produces long-lasting collagen stimulation but generally requires ongoing maintenance treatments.
Which treatment is best for collagen banking?
Both can contribute to a collagen banking strategy. The right choice depends on your age, anatomy, goals, and appetite for treatment sessions.
Can collagen stimulators support skin longevity?
Yes. Collagen stimulators are increasingly used as part of broader skin longevity strategies focused on maintaining skin quality, structural support, and healthy ageing.
What is the difference between regenerative aesthetics and traditional fillers?
Traditional fillers primarily replace lost volume. Regenerative treatments stimulate the body’s own repair mechanisms, encouraging collagen production and supporting long-term skin health.
Can Ellansé and Sculptra be used together?
In selected cases, yes. Some patients may benefit from a combination approach as part of a personalised regenerative treatment plan.
How do I know which treatment is right for me?
The right treatment is rarely determined by a product alone. It is determined by your anatomy, your stage of ageing, your skin quality, and your long-term goals. At Mediject, every recommendation begins with a comprehensive consultation because exceptional results come from understanding the whole face, not simply choosing a treatment.
Whether Ellansé, Sculptra, or another regenerative treatment is appropriate, the conversation should always begin with understanding how your face is ageing.
At Mediject, we do not build treatment plans around products. We build them around people.
Through a detailed consultation, we assess facial structure, skin quality, collagen health, and long-term goals to create a strategy focused on regeneration, longevity, and natural-looking outcomes.
Because exceptional results are rarely created in a syringe. They are created through thoughtful planning, clinical expertise, and a commitment to helping you age well.
Book a consultation at Mediject Clinic
